Styrax Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 M
- Revenue Growth 53.80%
- Profit Growth -90.48%
- Ebitda -86.47%
- Net Worth 2.54%
- Total Assets 120.23%
About Styrax Healthcare
Styrax Healthcare Private Limited (SHPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2013 and has a history of 11 years and 11 months. Its registered office is in Amritsar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.70 M.
Sangeeta Sharma, Suresh Sharma, Pranav Kashyap, and One other member serve as directors at the Company.
Company Details
- Location
Amritsar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100PB2013PTC037189
- Company No.
037189
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Styrax Healthcare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Sharma  | Director | 15-Oct-2020 | Current |
| Suresh Sharma | Director | 07-Mar-2013 | Current |
| Pranav Kashyap | Director | 20-Oct-2020 | Current |
| Lavnika Kashyap | Director | 07-Mar-2013 | Current |
Financial Performance of Styrax Healthcare.
Styrax Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 53.8% increase. The company also saw a substantial fall in profitability, with a 90.48% decrease in profit. The company's net worth moved up by a moderate rise of 2.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Styrax Healthcare?
In 2020, Styrax Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.70 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2021 | Indian Bank | ₹1.70 M | Open |
How Many Employees Work at Styrax Healthcare?
Unlock and access historical data on people associated with Styrax Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Styrax Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styrax Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
